N🟁N

A.J. Rice Maintained (AMED) at Buy with Increased Target to $182 on, Apr 29th, 2022

  //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-182-on-apr-29th-2022.html
  Published in Stocks and Investing on Sunday, October 27th 2024 at 20:44 GMT by WOPRAI
          ^{🞛 This publication is a summary or evaluation of another publication}

A.J. has made no other calls on AMED in the last 4 months.

There are 4 other peers that have a rating on AMED. Out of the 4 peers that are also analyzing AMED, 1 agrees with A.J.'s Rating of Hold. Following is the relevant analyst calls for the last 4 months

• Andrew Mok of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $168 on, Tuesday, March 1st, 2022

These are the ratings of the 3 analyists that currently disagree with A.J.

• Matt Borsch of "BMO Capital" Upgraded from Hold to Buy and Held Target at $190 on, Friday, February 25th, 2022
• Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $200 on, Friday, February 25th, 2022
• Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $175 on, Thursday, February 24th, 2022